A patient with severe asthma is non-responsive to high-dose ICS/LABA therapy and frequent exacerbations continue. Which biologic agent can be consider...

Question

A patient with severe asthma is non-responsive to high-dose ICS/LABA therapy and frequent exacerbations continue. Which biologic agent can be considered next?

Accepted Answer

Omalizumab

Answer

Methotrexate

Answer

Epoprostenol

Answer

Hydroxychloroquine

Answer

Sirolimus

MCQ (SBA): Severe asthma

A patient with severe asthma is non-responsive to high-dose ICS/LABA therapy and frequent exacerbations continue. Which biologic agent can be considered next?